Oh My I heard there will be telecon's this week with announcements. Not sure what about? Thanks the lord for nursing background to fall back, just in case
Trump is ruing the Republican party. Any of the other candidates could crush her in the election and you were sold by a magician. It's over and 100% of the blame for all she does lies with you idiot Republicans who choose him as your candidate.
Yes. We know this, Mr. Obvious. But what does it have to do with the subject of this thread? You are spamming.
Word on the street is we'll be getting Allergan's antibiotic portfolio that we were supposed to get during the merger. The Forest knuckle draggers that built that division out of cardboard over there are finally being looked at like the incompetent frauds they are.
Teflaro & AvyCaz are actually decent drugs & had the Forest idiots not screwed up pricing (manufacturing AvyCaz as well) both would have much greater market share. Under the Pfizer umbrella both will do much better. You'll be happy to have these products.
she is evil and so is a tax cheating, cat grabbing, veteran POW ridiculing, draft dodging, racist, sexist, clown with small fingers you just can't accept it - would you want him around your daughters? No you wouldn't but you are crazed zombie political followers.
7 IS DSMs butchered already. Remaining reps look intact until Q317, when it will be a blood bath. Guess what? You are the most expensive reps left at Pfizer. We don't need expensive reps. We need soldiers who will follow orders. You can't get in the hospitals anyway and if you do, it's in places that don't match up to our current portfolio. Go wear some scrubs and clogs and feel important, but you better be actively looking. Dermatology is a good place to land if you have a low salary. If you have a high salary, we aren't looking. If you have a high salary, you need to look outside. Plain and simple.
Q317, is that because we just do this every year in Q3? Or because of something else? We'll supposedly still have Eliquis, probably Chantix and still be biosimilars' bitch. Why Q317?
